⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Structure Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Structure Therapeutics
↗South San Francisco, USA
Structure Therapeutics is a clinical-stage global biopharmaceutical company focused on discovering and developing novel oral small-molecule therapeutics to treat chronic metabolic and cardiopulmonary diseases. The company leverages a next-generation structure-based drug discovery platform, incorporating artificial intelligence, machine learning, and computational chemistry to target G-protein coupled receptors (GPCRs).
By converting traditional biologic and peptide therapies into orally available small molecules, Structure Therapeutics aims to overcome limitations such as complex manufacturing, high costs, and the need for injections. Their pipeline is primarily focused on obesity and related metabolic conditions, with lead candidates in clinical development.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Metabolic diseases, Obesity, GPCR therapeutics
SIZE & FINANCIALS
Employees:201-500
Revenue:<$1M
Founded:2016
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:Qiming Venture Partners, F-Prime Capital, Sequoia
STOCK
Exchange:NASDAQ
Ticker:GPCR
Market Cap:$2.79B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 3 (planned 2H 2026)
Modalities:Small molecule
Active Trials:0
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various research collaborations related to GPCR structure-based drug design
COMPETITION
Position:Emerging
Competitors:Eli Lilly, Novo Nordisk, Viking Therapeutics, Altimmune
LEADERSHIP
Key Executives:
Raymond Stevens - CEO
Matthew Lang - COO and General Counsel
LINKS
Website:structuretx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Structure Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.